Plain-English translation of NCT05419024 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is investigating how HIV comes back in the body when people stop taking their antiretroviral medications for a short time. Researchers want to understand the earliest stages of viral rebound and use specialized imaging (called PET scans) combined with sensitive blood tests to detect even tiny amounts of HIV that might not show up on standard tests. This knowledge could one day help scientists develop better strategies to cure HIV or keep it controlled with fewer medications.
Even when people take HIV medications perfectly and have undetectable virus in their blood, the virus can hide in certain tissues and come back if treatment stops. Scientists don't yet fully understand how and where this rebound happens in the earliest days, which is making it hard to develop a cure. This study will fill that knowledge gap by carefully watching what happens during a temporary pause in treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would first have an imaging scan (a PET scan) while still on your regular HIV medications. Then researchers would randomly assign you to either continue your medications as usual, or temporarily stop them for up to 90 days. If you are in the treatment-interruption group, you'll have blood tests every week to watch your viral levels carefully, and your doctor will restart your medications immediately if your virus starts to rebound significantly or if you meet other safety thresholds. The study involves visits for imaging, biopsies (small tissue samples), and frequent blood draws over several months.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States